The Survey of Ipragliflozin Treatment in Elderly type2 Diabetes Patients

Study of Ipragliflozin in Patients With Type 2 Diabetes Mellitus Receiving Insulin Therapy

NCT02847091 ·Status: COMPLETED ·Phase: PHASE4

A Study to Assess the Efficacy and Safety of ASP1941 in Combination With Sulfonylurea in Type 2 Diabetic Patients

NCT01242215 ·Status: COMPLETED ·Phase: PHASE3

A Study to Assess the Long-term Safety and Efficacy of ASP1941 in Japanese Diabetic Patients

NCT01054092 ·Status: COMPLETED ·Phase: PHASE3

A Study to Assess the Safety and Efficacy of ASP1941 in Combination With Dipeptidyl Peptidase-4 (DPP-4) Inhibitor in Type 2 Diabetic Patients

NCT01242228 ·Status: COMPLETED ·Phase: PHASE3

A Study to Assess the Safety and Efficacy of ASP1941 in Combination With α-glucosidase Inhibitor in Type 2 Diabetic Patients

NCT01242202 ·Status: COMPLETED ·Phase: PHASE3

A Study to Assess the Efficacy and Safety of ASP1941 in Combination With Metformin in Type 2 Diabetic Patients

NCT01135433 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate Long-term Safety and Efficacy of ASP1941 in Diabetes Patients

NCT01672762 ·Status: COMPLETED ·Phase: PHASE3

A Study to Assess Safety and Efficacy of ASP1941 in Combination With Nateglinide in Type 2 Diabetic Patients

NCT01316107 ·Status: COMPLETED ·Phase: PHASE3

A Study to Assess the Efficacy and Safety of ASP1941 in Combination With Pioglitazone in Type 2 Diabetic Patients

NCT01225081 ·Status: COMPLETED ·Phase: PHASE3

Double-blind Ipragliflozin Add-on Study in Japanese Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Sitagliptin (MK-0431J-843)

NCT02577003 ·Status: COMPLETED ·Phase: PHASE3

Meta-analysis in Post-marketing Surveillances for SGLT2 Inhibitors in Patients With Type 2 Diabetes Mellitus

NCT02284269 ·Status: UNKNOWN

Evaluate Efficacy and Safety in Japanese Subjects With Type 2 Diabetes Mellitus

NCT01294423 ·Status: COMPLETED ·Phase: PHASE3

Evaluate Safety as Mono or Combination Therapies With Anti-diabetes Mellitus Drugs in Japanese Subjects With Type 2 Diabetes Mellitus

NCT01294436 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Alogliptin Used in Combination With Sulfonylurea in Participants With Type 2 Diabetes in Japan

NCT01318083 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Ipragliflozin Add-on Long-term Study in Japanese Participants With Type 2 Diabetes Mellitus on Sitagliptin (MK-0431J-849)

NCT02564211 ·Status: COMPLETED ·Phase: PHASE3

A Study of ASP1941 in Japanese Patients With Type 2 Diabetes Mellitus

NCT01023945 ·Status: COMPLETED ·Phase: PHASE1

Safety, Pharmacokinetics and Pharmacodynamics of Two IDegAsp (One Explorative) Preparations and Two Insulin Degludec (One Explorative) Preparations in Japanese Subjects

NCT01868555 ·Status: COMPLETED ·Phase: PHASE1

Safety, Tolerability and Pharmacokinetic and Pharmacodynamic Characteristics of Explorative Formulations of Insulin Degludec and IDegAsp 50 in Healthy Japanese Subjects

NCT01865331 ·Status: COMPLETED ·Phase: PHASE1

To Study Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD1656 in Japanese Type 2 Diabetes Mellitus (T2DM) Patients

NCT00916604 ·Status: COMPLETED ·Phase: PHASE1

Role of Rosiglitazone on Pre-Diabetes Mellitus and Coronary Artery Disease

NCT01574820 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate P-Glucose, Safety and Tolerability After Oral Single Dosing of AZD6370 in Type 2 Diabetic Patients

NCT00690287 ·Status: COMPLETED ·Phase: PHASE1

Alogliptin Tablets Specified Drug-use Survey "Type 2 Diabetic Patients Receiving Combination Therapy With a Hypoglycemic Agent (e.g., Insulin Preparations or Rapid-acting Insulin Secretagogues)"

NCT02221284 ·Status: COMPLETED

Pioglitazone Tablets Specified Drug-use Survey <Survey on Glycemic Control in Type 2 Diabetic Patients With a History of Cerebral Infarction>

NCT02181842 ·Status: COMPLETED

FLuctuATion Reduction With inSULin and Glp-1 Added togetheR (FLAT-SUGAR)

NCT01524705 ·Status: COMPLETED ·Phase: PHASE4

A Study to Test How Well Empagliflozin Works in Japanese People With Type 2 Diabetes Who Are Older Than 65 Years

NCT04531462 ·Status: COMPLETED ·Phase: PHASE4